Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT
1VT Analyst Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1VT Stock 12 Month Forecast
Average Price Target
€75.52
▲(196.16% Upside)
| Highest Price Target€90.35 | Average Price Target€75.52 | Lowest Price Target€59.11 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
€90.35
Buy
254.30%
Upside
Reiterated
02/13/26
Truist Financial
Buy
―
Reiterated
02/12/26
Stifel Nicolaus
€80.21
Buy
214.57%
Upside
Reiterated
02/12/26
H.C. Wainwright
€86.12
Buy
237.74%
Upside
Reiterated
02/12/26
William Blair
Buy
―
Reiterated
02/12/26
Piper Sandler
€59.95
Buy
135.10%
Upside
Reiterated
02/12/26
Morgan Stanley
€86.12→€83.59
Buy
227.81%
Upside
Reiterated
02/12/26
Jefferies
€85.28
Buy
234.43%
Upside
Reiterated
02/12/26
J.P. Morgan
€63.33
Buy
148.34%
Upside
Reiterated
02/11/26
Maxim Group
€59.11
Buy
131.79%
Upside
Reiterated
02/11/26
BTIG
€105.54
Buy
313.90%
Upside
Reiterated
10/30/25
Leerink Partners
€99.63
Buy
290.72%
Upside
Reiterated
10/23/25
Cantor Fitzgerald
€87.81→€88.66
Buy
247.68%
Upside
Reiterated
10/23/25
Oppenheimer
€84.44
Buy
231.12%
Upside
Reiterated
10/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
€90.35
Buy
254.30%
Upside
Reiterated
02/13/26
Truist Financial
Buy
―
Reiterated
02/12/26
Stifel Nicolaus
€80.21
Buy
214.57%
Upside
Reiterated
02/12/26
H.C. Wainwright
€86.12
Buy
237.74%
Upside
Reiterated
02/12/26
William Blair
Buy
―
Reiterated
02/12/26
Piper Sandler
€59.95
Buy
135.10%
Upside
Reiterated
02/12/26
Morgan Stanley
€86.12→€83.59
Buy
227.81%
Upside
Reiterated
02/12/26
Jefferies
€85.28
Buy
234.43%
Upside
Reiterated
02/12/26
J.P. Morgan
€63.33
Buy
148.34%
Upside
Reiterated
02/11/26
Maxim Group
€59.11
Buy
131.79%
Upside
Reiterated
02/11/26
BTIG
€105.54
Buy
313.90%
Upside
Reiterated
10/30/25
Leerink Partners
€99.63
Buy
290.72%
Upside
Reiterated
10/23/25
Cantor Fitzgerald
€87.81→€88.66
Buy
247.68%
Upside
Reiterated
10/23/25
Oppenheimer
€84.44
Buy
231.12%
Upside
Reiterated
10/07/25
Best Analysts Covering Viking Therapeutics
3 Months
xxx
Success Rate
13/23 ratings generated profit
Average Return
+33.15%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.52% of your transactions generating a profit, with an average return of +33.15% per trade.
1 Year
Success Rate
14/25 ratings generated profit
Average Return
+126.34%
reiterated a buy rating 10 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 56.00% of your transactions generating a profit, with an average return of +126.34% per trade.
2 Years
xxx
Success Rate
14/25 ratings generated profit
Average Return
+190.11%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 56.00% of your transactions generating a profit, with an average return of +190.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1VT Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
29
20
18
10
14
Buy
8
5
5
4
4
Hold
1
0
1
8
19
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
25
24
22
37
Each month's total comprises the sum of three months' worth of ratings.
1VT Financial Forecast
1VT Stock Forecast FAQ
What is DE:1VT’s average 12-month price target, according to analysts?
Based on analyst ratings, Viking Therapeutics’s 12-month average price target is 75.52.
What is DE:1VT’s upside potential, based on the analysts’ average price target?
Viking Therapeutics has 196.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Viking Therapeutics a Buy, Sell or Hold?
Viking Therapeutics has a consensus rating of Strong Buy, which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Viking Therapeutics’s share price target?
The average share price target for Viking Therapeutics is 75.52. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €90.35 ,and the lowest forecast is €59.11. The average share price target represents 196.16% Increase from the current price of €25.5.
The highest analyst share price target is €90.35 ,and the lowest forecast is €59.11. The average share price target represents 196.16% Increase from the current price of €25.5.
What do analysts say about Viking Therapeutics?
Viking Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of Viking Therapeutics?
To buy shares of DE:1VT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.